In the first of a two-part series, Banner Witcoff’s Mercedes Meyer and Brandon Phemester of Novavox explore how legislative, judicial, and executive policies have dramatically altered the risks for drug innovation.
Find the full article here.
Paid registration is required to view.
Posted: September 11, 2025
